Compounds > rosiglitazone
Page last updated: 2024-08-25

rosiglitazone and sb 203580

rosiglitazone has been researched along with sb 203580 in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H1
Eggo, MC; Holder, JC; Kumar, S; Patel, NG; Smith, SA1
Chan, JY; Chan, SH; Chang, AY; Ho, YH; Wu, CA; Wu, KL1
Allen, SR; Cawyer, CR; Horvat, D; Jones, RO; Kuehl, TJ; Leonard, D; Uddin, MN; Zawieja, DC1
Duan, XC; Guo, XJ; Luo, YH; Ouyang, PB; Tian, J1
Beeram, MR; Kohl-Thomas, BM; Kuehl, TJ; Lin, S; Nguyen, T; Pantho, AF; Uddin, MN; Zawieja, DC1
Afroze, SH; Allen, S; Cawyer, C; Drever, N; Jones, R; Kuehl, T; Uddin, MN; Zawieja, DC1

Other Studies

7 other study(ies) available for rosiglitazone and sb 203580

ArticleYear
Identifying off-target effects and hidden phenotypes of drugs in human cells.
    Nature chemical biology, 2006, Volume: 2, Issue:6

    Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship

2006
Differential regulation of lipogenesis and leptin production by independent signaling pathways and rosiglitazone during human adipocyte differentiation.
    Diabetes, 2003, Volume: 52, Issue:1

    Topics: Adipocytes; Androstadienes; Cell Differentiation; Cell Survival; Cells, Cultured; Enzyme Inhibitors; Flavonoids; Humans; Imidazoles; Leptin; Lipid Metabolism; Lipids; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pyridines; Rosiglitazone; Signal Transduction; Sirolimus; Stem Cells; Thiazoles; Thiazolidinediones; Tumor Necrosis Factor-alpha; Wortmannin

2003
Transcriptional upregulation of mitochondrial uncoupling protein 2 protects against oxidative stress-associated neurogenic hypertension.
    Circulation research, 2009, Oct-23, Volume: 105, Issue:9

    Topics: Adenosine Triphosphate; Angiotensin II; Animals; Antioxidants; Blood Pressure; Blood Vessels; Catalase; Cell Respiration; Cyclic N-Oxides; Disease Models, Animal; Enzyme Inhibitors; Homeostasis; Humans; Hydrogen Peroxide; Hypertension; Imidazoles; Ion Channels; Male; Medulla Oblongata; Microinjections; Mitochondria; Mitochondrial Proteins; NADPH Oxidases; Onium Compounds; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphorylation; PPAR gamma; Pyridines; Rats; Rats, Sprague-Dawley; RNA-Binding Proteins; Rosiglitazone; Spin Labels; Superoxide Dismutase; Superoxide Dismutase-1; Superoxides; Sympathetic Nervous System; Thiazolidinediones; Time Factors; Transcription Factors; Transcriptional Activation; Transduction, Genetic; Uncoupling Protein 2; Up-Regulation

2009
Hyperglycemia impairs cytotrophoblast function via stress signaling.
    American journal of obstetrics and gynecology, 2014, Volume: 211, Issue:5

    Topics: Antigens, CD; Diabetes, Gestational; Endoglin; Enzyme-Linked Immunosorbent Assay; Female; Glucose; Humans; Hyperglycemia; Hypoglycemic Agents; Imidazoles; Interleukin-6; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Placenta Growth Factor; Plasminogen Activator Inhibitor 1; Polymerase Chain Reaction; PPAR gamma; Pregnancy; Pregnancy Proteins; Pyridines; Receptors, Cell Surface; Rosiglitazone; Signal Transduction; Thiazolidinediones; Trophoblasts; Urokinase-Type Plasminogen Activator; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1

2014
Rosiglitazone inhibits TGF-β 1 induced activation of human Tenon fibroblasts via p38 signal pathway.
    PloS one, 2014, Volume: 9, Issue:8

    Topics: Cell Transdifferentiation; Cells, Cultured; Enzyme Inhibitors; Humans; Hypoglycemic Agents; Imidazoles; MAP Kinase Signaling System; Myofibroblasts; p38 Mitogen-Activated Protein Kinases; Pyridines; Rosiglitazone; Tenon Capsule; Thiazolidinediones; Transforming Growth Factor beta1

2014
Hyperglycemia down-regulates cGMP-dependent protein kinase I expression in first trimester cytotrophoblast cells.
    Molecular and cellular biochemistry, 2015, Volume: 405, Issue:1-2

    Topics: Cell Line; Cyclic GMP; Cyclic GMP-Dependent Protein Kinase Type I; Down-Regulation; Female; Glucose; Guanylate Cyclase; Humans; Hyperglycemia; Imidazoles; Pregnancy; Pregnancy Trimester, First; Pyridines; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Signal Transduction; Soluble Guanylyl Cyclase; Thiazolidinediones; Trophoblasts

2015
Attenuation of hyperglycemia-induced apoptotic signaling and anti-angiogenic milieu in cultured cytotrophoblast cells.
    Hypertension in pregnancy, 2016, Volume: 35, Issue:2

    Topics: Apoptosis; bcl-2-Associated X Protein; Caspase 9; Cells, Cultured; Cyclooxygenase 2; Enzyme Inhibitors; Female; Glucose; Humans; Hyperglycemia; Hypoglycemic Agents; Imidazoles; Interleukin-6; p38 Mitogen-Activated Protein Kinases; Placenta Growth Factor; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Pyridines; Rosiglitazone; Signal Transduction; Thiazolidinediones; Trophoblasts; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1

2016